Neopterin, serum amyloid A, and cytokine monitoring after renal transplantation

Pteridines

Volumn 9, Issue 2, 1998, Pages 113-121

  Neumann, M Christine ^a   Sprenger, Hans ^a   Grebe, Scott O ^a   Gemsa, Dietmar ^a   Reibnegger, Gilbert ^b   Lange, Harald ^a   Müller, Thomas F ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Amyloid A; Cytokine; Neopterin; Renal transplantation

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; NEOPTERIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; BLOOD LEVEL; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHELOMETRY; PATIENT MONITORING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; URINE LEVEL; VIRUS INFECTION;

EID: 0031688054     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.1998.9.2.113     Document Type: Review

References (26)

1. Auchincloss H, Sachs DH. Transplantation and graft rejection. In: Paul WE. Fundamental Immunology. New York: Raven Press 3rd ed. 1993; 1099-1142.
2. Dallman MJ. The cytokine network and regulation of the immune response to organ transplants, Transpl Revs 1992; 6: 209-217.
3. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: An overview, Transplant Immunol 1993; 1: 3-27.
4. Schmouder RL, Kunkel SL. The cytokine response in renal allograft rejection, Nephrol Dial Transplant 1995; 10 (Suppl 1): 36-43.
5. Castell JV, Gomez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes, FEBS Lett 1989; 242(2): 237-239.
6. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: A prominent acute phase reactant for clinical practice, Eur J Clin Invest 1996; 26: 427-435.
7. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases, Crit Rev Clin Lab Sciences 1992; 29(3): 307-341.
8. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G. Neopterin. Biochemistry-Methods-Clinical Application. Berlin/New York: Walter de Gruyter 1992.
9. Attallah AM, Abdelghaffar H, Alghraoui F, Fawzy A, Alijani MR, Mahmoud LA, Ghoneim MA, Helfrich GB. Immunological monitoring and early prediction of rejection in renal allograft recipients, Int Archs Allergy Appl Immun 1987; 84: 10-17.
10. Colvin RB, Preffer FI, Fuller TC, Brown MC, Ip SH, Kung PC, Cosimi AB. A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients, Transplantation 1989; 48(5): 800-804.
11. McLaughlin PJ, Aikawa AA, Davies HM, Ward RG, Bakran A, Sells RA, Johnson PM. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients, Transplantation 1991; 51(6): 1225-1229.
12. Reibnegger G, Aichberger C, Fuchs D, Hausen A, Spielberger M, Werner ER, Margreiter R, Wachter H. Posttransplant neopterin excretion in renal allograft recipients - A reliable diagnostic aid for acute rejection and predictive marker of longterm graft survival. Transplantation 1991; 52(1): 58-63.
13. Müller T, Schindler S, Sprenger H, Steinmetz A, Hocke G, Ebel H, Gemsa D, Lange H. Prospective analysis of 10 different parameters of acute renal allograft rejection, Transplant Proc 1992; 24(6): 2731-2734.
14. Hocke G, Ebel H, Bittner K, Müller T, Kaffarnik H, Steinmetz A. A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection, Klin Wochenschr 1989; 67: 447-451.
15. Häyry P, von Willebrand E, Parthenais E, Nemlander A, Soots A, Lautenschlager I, Alfoldy P, Renkonen R. The inflammatory mechanisms of allograft rejection, Immunol Rev 1984; 77: 85-142.
16. Harris KR, Digard NJ, Lee HA. Serum C reactive protein, Transplantation 1996; 61(11): 1593-1600.
17. Sprenger H, Meyer RG, Kaufmann A, Bußfeld D, Rischkowsky E, Gemsa D. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection, J Exp Med 1996; 184: 1191-1196.
18. Male D, Cooke A, Owen M, Trowsdale J, Champion B. Advanced immunology. London: Mosby 3rd ed. 1996.
19. Sheldon J, Riches PG, Soni N, Jurges E, Gore M, Dadian G, Hobbs RJ. Plasma neopterin as an adjunct to C reactive protein in assessment of infection, Clin Chem 1991; 37(12): 2038-2042.
20. Dinarello CA, Mier JW. Current concepts of lymphokines, N Engl J Med 1987; 137(15): 940-945.
21. Ramadori G, Van Damme J, Rieder H, Meyer zum Buschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumor necrosis factor-α, Eur J Immunol 1988; 18: 1259-1264.
22. Maury CPJ, Teppo AM, Ahonen J. Post-transplantation monitoring of high-density lipoprotein-associated serum amyloid A protein: A new diagnostic aid in the detection of renal allograft rejection, Uremia Invest 1986; 9(2): 277-280.
23. Schafer AJ, Daniel V, Dreikorn K, Opelz G. Assessment of plasma neopterin in clinical kidney transplantation, Transplantation 1986; 41(4): 454-459.
24. Magalini SC, Nanni G, Agnes S, Avolio AW, Salvatori M, Manna R, Castagneto M. Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection, Transplant Proc 1991; 23(4): 2267-2268.
25. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories, Clin Chem 1989; 35(6): 990-994.
26. Müller TF, Grebe SO, Neumann MC, Lange H, Reibnegger G. Die Zeit als Schlusselvariable beim immunologischen Monitoring nach Organtransplantation, Berichte der ÖGKC 1998 (in press).